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Enposure to fibroblast-eonditioncd eortisol-eontaining medium increased fatty acid synthas¢ activity and f~tty acid syntltas¢, acetyl-CoA carbox- 
ylase and ATP citrate lyase mRNA abundance in fetal type II alveolar epithelial cells. Both fibroblast conditioning and cortisol in the medium 
were required for maximal effect on the mRNA levels, indieatin~ involvement of mesenehymal-¢pith¢lial interaction i  the ¢ortisol effects. The 
observed effects provide vidence for an earlier hypothesis that increased activity of CTP:phosphocboline cytidylyltransfera~e in lung tissue caused 
by ghcocorticoid s due to increased fatty acid synthesis. However, evidence suggesting pre-translat ional regulation fthis enzyme by glucoeortieoid 
was also found. 
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1. INTRODUCTION 
Pulmonary surfactant, the surface-active material 
that prevents alveolar collapse and transudation, con- 
sists of  approximately 90% lipid and 10% protein [1]. 
Dipalmitoylphosphatidylcholine is the major active 
conlponent [1]. The surfactant is produced by the type 
II alveolar epithelial cells [2,3]. Its formation in the fetal 
lung is greatly accelerated towards the end of gestation 
[4,5] and endogenous glucocorticoids are involved in 
this process [6fl]. The effect of glucocorticoids on the 
acceleration of  surfactant lipid synthesis is dependent 
on mesenchymal--epithelial interaction. This was con- 
eluded from studies vAth type II cells and fibroblasts 
isolated from fetal lung showing that the stimulation by 
glucocorticoid of the synthesis in type II cells of disatu- 
rated phosphatidylcholine (DSPC), which is mainly di- 
palmitoylphosphatidylcholine, is mediated by a fibro- 
blast-pneumonocyte factor (FPF) that is produced by 
lung fibroblasts under the influence of glucocorti~id 
[8-11]. Fetal rat type II cells exposed to fibroblast-con- 
ditioned, cortisol-containing medium showed an incor- 
poration of [MeJH]choline into DSPC that was 179% 
of the value seen after exposure to control medium [9]. 
As in other cells, CTP:phosphocholine cytidylyltrans- 
ferase (CPCT) catalyzes a rate-regulatory step in 
phosphatidylcholine formation by type II cells [12,13]. 
Maternal administration of dexamethasone leads to an 
increased activity of CPCT in type II cells isolated from 
rat fetuses [14]. In fetal rat type II ceils exposed to 
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fibroblast-conditioned, cortisol-containing medium the 
CPCT activity was increased 2-fold compared to con- 
trol medium [11]. 
The activities of fatty acid synthase (FAS) [15,16] and 
aeetyl-CoA carboxylase (ACC) [16017] and the rate of 
fatty acid synthesis [15,17] in fetal rat lung show a peak 
in the period of accelerated surfactant formation. In this 
period there is also a peak (around fetal day 21; with an 
increase of 70-100% between fetal days 19 and 21) in 
the abundance of the mRNAs of FAS, ACe  and ATP 
citrate lyase (ACL) in fetal rat lung [18], indicating pre- 
translational regulation of these enzymes in the perina- 
tal period. FAS activity in fetal lung tissue is increased 
by glucocortieoids, both in vivo [15] and in explant 
culture [19-21]. The increased FAS activity in lung ex- 
plant culture is due to induction of this enzyme [19], 
which is brought about at a pre-translation,al level [22]. 
Recently, it was observed that glucocorticoid in- 
creased the activity but not the amount of CPCT in 
explants of fetal rat lungs [23] and that inhibition of 
fatty acid synthesis abolished the stimulatory effect of 
glucocorticoid on CPCT in these lungs [20]. Based on 
these findings and earlier observations that the activity 
of CPCT in lung can be stimulated by fatty acids and 
various phospholipids [24,25], Rooney and col- 
laborators [23°26] hypothesized that the stimulatory ef- 
fect of glucocorticoids on CPCT activity in fetal lung is 
the result of increased synthesis of" fatty acids which, 
either as free fatty acids or after incorporation into 
phospholipids, activate CPCT. 
We have previously shown that exposure of type II 
cells isolated from fetal rat lung to flbroblast-condi- 
tioned, cortisol-containing medium leads to an enhance- 
ment of fatty acid sy~athesis in these cells [16]. The pres- 
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ent study was undertaken to investigate whether, under 
the same conditions, the activity of FAS is increased 
and if so, whether this is brought about at a pre-transla- 
tional level. Moreover~ it was studied whether there is 
pre-translational regulation of other enzymes involved 
in fatty acid synthesis and of CPCT. In addition, we 
asked ourselves the question whether fibroblast-type II
cell interaction is required for the effects. 
2. MATERIALS AND METHODS 
2,1. Materials 
The followin/~ plasmids were used to make probes/'or Northern blot 
hybridization analysis: clone pl 8,1-6 (0.5 kb insert encoding rat mam- 
mary gland ACC), clone pFAS.5 (1.1 kb insert encoding mouse liver 
FAS [27]), clone pACL2 (1.5 kb insert encoding mouse liver ACL 
[28]), clone pR ME1 (2.4 kb insert encoding rat liver malic enzyme 
[29]), a clone containing a 1,3 kb insert encoding rat liver CPCT [30], 
clone pHFFlA-3°UT-HF (0.4 kb insert encoding human fl-cytoplasmic 
actin [31]) and clone pHeGAP (1,2 kb insert encoding human liver 
glyceraldehyde-3-phosphate dehydrogenasc [32], [a-'a"P]dATP (3,000 
Ci/mmol) was obtained from New England Nuclear (Wilmington, 
DE), Pregnant Wistar rats of known gestation time (term is at day 22) 
were l~a~'chas'~l from Harlan-CPB in Zeist, The Netherlands, 
2.4. Isolation and Northern blot hybrldi-.attan ofRNA 
After exposure to various media, cells on 10-¢m dishes were rin~.d 
with phosphate.buffered saline (pH 7.4} an d . subsequently scraped 
from the dish~ in 4 M guanidinium thiocyanate, 25 mM sodium 
citrate, 0.5% sodium N.iaumoylsarcosine, 0.1% antifoam A. 0,1 M 
]~-mereaptoethancl [35 (3 ml l~r 6 dishes). The viscous t~pension 
was homogenized with an Ultra-Turrax mixer {Janke and Kunkel, 
Staufen i.l]r., Germany) at 0°C. From this homogenate the RNA was 
separated by CsCI centrifugation [35]. RNA was quantified by meas- 
uring the absorbance at260 nm. Aliquots ~ntaining 50/zg total RNA 
were resolved by electrophoresis through a 1.2% agaro~e-formalde- 
hyde gel 136l, After the separation the RNA was transferred tonylon 
membrane (Nytran-N; Schleicher and Schuell, '~-Hertogenboseh, The
Netherlands) by capillary blotting, Staining with Methylene blue 
showed that ~lual amounts of RNA were pr in t  on the blot in each 
lane. The blots were heated at 80"C for 2 h. They were prehybridizcd 
for 3 h and subsequently h bridized for 16-18 h as described [18] using 
0.25/.tg ~2P-labeled DNA, The P'P-labeled probes (approx. 4 × 10 ~ 
cpm/~tg DNA} were prepared by random priming [37l from [~- 
~'P]dATP and eDNA inserts that had been excised from the plasmids 
with the appropriate r striction enzymes. After hybridization the blots 
were washed [18] and autoradiograms of the blots wet© made at 
-80°C. The intensities of the hybridization signals on the autoradi- 
ograms were quantified by densitometry, using an LKB Ultrosean XL 
laser densitometer, FAS, malic enzyme, Ace ,  ACL and CPCT 
rnRNAs were analyzed on fresh blots. After washing of the blots for 
1 h at 100°12 in 0.05 x SSPE, I% sodium dodecyi ~ulfate to remove 
the probe, they were re-hybridized with fl-actin probe and subse- 
quently with glyceraldehydephosphate dehydrcgenas~ probe, 
2.2, Cell tsolation and incubation 
Type II cells and fibroblasts were isolated from 19-day fetal rat 
lungs by differential dherence, as described before [33]. 
Conditioned m~ia were prepared as described by Post and Smith 
[10] in an article demonstrating the involvement of type I1 cell,-flbro- 
blast interaction i the stimulation by cortisoi of phosphatidylchollne 
synthesis in type II cells. Fibroblasts, that had attached to T-flasks 
during the first l.h attachment period [33] in minimal essential me. 
dium (MEM) containing 10% fetal bovine serum were rinsed with 
serum-free MEM and grown to confluence in MEM containing 10% 
charcoal-stripped newborn calf serum, At confluence, fibroblasts were 
rinsed with serum-free MEM and subsequently incubated for 48 h in 
either serum-free MEM containing 10 -7 M cortisol or MEM without 
eortisol. After the exposure the medium was collected, centrifuged to 
remove any detached cells, incubated for 2 h at 58"C 18,10] and stored 
at -20°C. Portions ofthe MEM and MEM containing 10 -7 M ¢ortisol 
that had not been exposed to fibroblasts were treated in the same 
mamaer. 
The effect of the various media on alveolar type II cells, tlmt had 
attached uring a l-night adherence Period [33] in MEM containing 
10% fetal bovine serum, was determined by aspirating the old medium, 
rinsing the ¢~lls with ~erum-fr~ MEM, and subsequently incubating 
them for 20 h in each of the media pre-mixed 1:1 with serum-free 
MEM. These 1:1 dilutions are hereafter referred to as control MEM 
(prepared with non-conditioned MEM), MEM/cort (with cortisol- 
containing MEM), MEM/FIb (with fibroblast-eonditioned MEM} and 
MEM/cort/fib (with fibroblast-conditioned, eortisol-containing 
MEM). The MEM used in these experiments contained 100 U/ml 
penicillin, 1(30 #g/ml kanamycin and 2.5/~g/ml amphotoricin B.
2.3, Fatty acid synthase assay 
After exposure to control MEM or MEM/cort/fib, cells on 10-era 
dishes were rinsed 3 time.s with 10 mM Tri~: 0,25 rA sucrose (pH 7.4) 
and scraped from the dishes in a small volume of this buffer, using a 
rubber policeman, They were disintegrated bysonieation (4 x 15 s at 
0*C; frequency 23 kHz; amplitude 6 ltm). Fatty acid synthase activity 
in the sonieates was measured spectrophotometrimlly [15]. The pro- 
rein content of the sonieates was d©tcrmin~ according to Lowry et 
al, [34], using bovine serum albumin as the standard. 
3. RESULTS 
3.1. Fatty acid synthase activity 
In a previous tudy we observed that exposure of fetal 
rat type II cells to MEM/eortJfib instead of control 
MEM led to an enhancement of fatty acid synthesis by 
50% [16]. In the present investigations we exposed the 
fetal type 1I cells to the same medium and subsequently 
measured the activity of FAS in sonicated cells. In the 
sonicated control cells (ceils cultured for 20 h in control 
MEM) the specific .activity of FAS was 1.47 _ 0.34 
nmol/min.mg protein (mean _ S.E.M.; n=6). Because of 
the variability of this control value, the FAS activity 
upon MEM/cort/fib exposure was calculated as a per. 
centage of the control value for each experiment. In the 
6 experiments the activity in the type II cells exposed to 
MEM/cort/fib was 208 +_ 37% (mean +_ S.E.M.) of the 
activity in cells exposed to control MEM (P<0.005 ac. 
cording to Student's t-test). The previously observed 
[i6] rise in the rate of fatty acid synthesis is therefore 
accompanied by a significantly enhanced FAS activity. 
3.2. Abundance of the mRNAs for FAS, ACC, ACL and 
malic enzyme 
As we had no way to measure the absolute quantities 
of the mRNAs, we measured only relative levels. For 
this purpose equal amounts of total RNA were analyzed 
by Northern blot hybridization. Table I shows that ex- 
posure of the type II cells to MEM/cort/fib instead of 
control MEM led to a significant rise in the abundance 
of FAS mRNA, indicating that the increased FAS activ- 
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ity observed under this condition was at least partially 
due to pre-translational regulation. Exposure to MEM/ 
cart/fib instead of control MEM also led to increased 
abundance of the mRNAs encoding ACC and ACL 
(Table I). No change was seen in the abundance ofmalic 
enzyme mRNAs (Table I). This is reminiscent of the 
results obtained in a study on the developmental pat- 
terns of the mRNAs of lipogenic enzymes in fetal rat 
lung. In that study [18] pre-translational regulation of 
FAS, ACC and ACL, but not of malic enzyme, was 
observed. 
It can be seen from Table I that the increase in the 
abundance of FAS mRNA due to exposure to MEM/ 
cart/fib was not found upon exposure to either MEM/ 
cart or MEM/fib, The abundance of ACC mRNA and 
ACL mRNA was significantly higher than the control 
value upon exposure to MEM/cort but, as in the case 
of FAS mRNA, the "values een after exposure to MEM/ 
tort/fib were significantly higher than those seen after 
exposure to each of the other media. This indicates that 
both the eortisol in the medium and fibroblast condi- 
tioning are necessary for the maximal effect. The small 
increasing effect of MEM/cort exposure on ACC and 
ACL mRNA in the type II cell preparations may be due 
to contaminating fibroblasts. 
That the effect on the abundance of FAS, ACe and 
ACL mRNA in the fetal type II cells is not an aspeeific 
effect on mRNAs in general can be concluded from the 
absence of an effect on the mgNAs of malic enzyme° 
glyceraldehydephosphate dehydrogenase and ,8-aetin 
(Table I). The latter two are often used as internal con- 
trols in studies like the present one. 
3.3. Changes fl~ the abundance of CPCT mRNA 
Table I shows that exposure of fetal type II cells to 
MEM/cort/fib instead of control MEM does not only 
lead to an increased abundance of the mRNAs or FAS, 
ACC and ACL, but also to that of the 5 and 1.5 kb 
Table I 
Relative abundance of mRNAs in fetal type I1 cells after exposure to various culture media 
mRNA Relative abundance 
(% of value after exposure to control MEM (condition 1)) 
MEM/cort MEM/FIb MEM/cort/fib 
(condition 2) (conditio:l 3) (condition 4) 
Fatty acid syntbase 134.3__. 10.4 (5) 135,6z 21.3 (5) 200.3-+38,2 (7) 
[41 [4] [i.2,3] 
Acetyl.CoA earboxylase 133,2:1:2,5 (5) 123,2:1:7.5 ( ) 185.7_+18,7 ( ) 
[1,4] I4] [1,2,3] 
ATP citrate lyase 125,7±4,0 (5) 99.0_+11.5 ( ) 160.8± 11,6 (7) 
[i.3,4] [2,4] [1.2,31 
Malic enzyme 
3,4 kb 104,9_+11.0 (5) 128.0±19,9 (5) 119,9+12.3 (6) 
2.4 kb 111,9-+8.1 (5) 116.3+_17,3 (5) 92,3±8.9 (6) 
Glyceraldehydephos- 
phate dehydrogenas¢ 107,7-+3.1 (5) 108,8±4.1 (5) 109,8:t:4.1 (6) 
.8.Actin 100,6_-.2,4 (5) 107,2__.2.8 (5) 94.8*_.3.2 (6) 
CTP: phosphocl'lolinc 
c),tidylyltransferase 
5 kb 108.1+6.5 (5) 96,8_+6.8 (5) 128,3_+9.7 (6) 
[4] [41 ti,:.3] 
1.5 kb 121.9"t-6.3 (5) 113,5__.5.3 (5) 136.5"t-12.4 (6) 
[n.s.l [41 [1.31 
RNA was isolated as described in section 2 from type 11 cells exposed to control MEM (condition 
1), MEM/cort (condition 2), MEM/fib (condition 3) or MEM/cort/fib (condition 4) and analyzed 
by Northern blot hybridization. For the various proteins the mean value for the mR1NA upon 
exposure of type lI cells to control MEM had an S.E.M. of 4-17%. For each experiment the relative 
abundance of a particular mRNA was expressed as a percentage of the abundance after exposure 
to control MEM, The values in the table represent the mean _ S,E,M, of these latter percentages, 
The figures in parenthesis indicate the number of experiments, In 5 experiments allfour conditions 
were included, In 2 other experiments only conditions 4 and I were compared, Each experiment was 
c~rried oat with a separate cell preparation, Statistical analysh '~vas carried out by analysis of 
variance. Only in those eases where the F-test indicated that there was a significant difference 
(F.~0.05) among exposure conditions, were means compared pair-wise by Student's t-test, The 
numbers in square brackets indicate for each condition from which other conditions its value differs 
nignificantly according to the t-test (P<0,05). [n.s,], not significantly different (P>0.05) from any 
other condition according to the t-test, No significant differ,nee among exposure conditions was 
indicated by the F-test for the mgNAs of malic enzyme, glyceraldehydophosphate dehydrogenase 
and ,t/-aetin, 
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mRNAs of CPCT. The abundance of the CPCT 5 kb 
mRNA upon exposure to MEM/cort/fib is significantly 
higher than that upon exposure to each of the other 
media, indicating the importance of both the cortisol 
and the fibroblast conditioning for maximal effect. 
MEM/cort exposure caused a (not statistically signifi- 
cant) increase in the abundance of CPCT 1.5 kb 
mRNA. As a result, for this 1.5 kb mRNA, the addi- 
tional effect of fibroblast-conditioning was not statisti- 
cally significant. 
4. DISCUSSION 
The present experiments show for the first time that 
exposure to fibroblast-conditioned, cortisol-containing 
medium causes an increased FAS activity in isolated 
fetal type II cells, and that this effect is at least partially 
brought about by pre-translational regulation. The 
same medium also increases the abundance of the 
mRNAs of two other enzymes involved in fatty acid 
synthesis, ACC and ACL. These data indicate that ore- 
translational regulation of  FAS, ACC and ACL is prob- 
ably involved in the increased rate of fatty acid synthesis 
observed in fetal type II cells upon exposure to fibro- 
blast-conditioned, cortisol-containing medium [16] and 
in whole lung upon glucocorticoid exposure [21]. The 
observation that the cortisol effect on the abundance of 
FAS, ACC and ACL mRNAs is significantly less when 
the eortisol-containing medium is not conditioned by 
lung fibroblasts indicates that naesenchymal-epithelial 
interaction is involved in the induction of fatty acid 
synthesis. The FPF that has been described as stimulat- 
ing DSPC synthesis [8-10] and CPCT activity [11] in 
fetal type II cells may also be involved in the stimulation 
of fatty acid synthesis in these cells. However, it should 
be noted that our experiments do not distinguish be- 
tween (i) an effect via a factor produced in the fibro- 
blasts upon exposure to cortisol, and (ii) an effect via 
a combination of cortisol and a factor that is secreted 
by the fibroblasts even if they are not exposed to corti- 
sol. 
The regulation of CPCT activity and its intracellular 
site of action are incompletely known. A number of 
mechanisms for its activation have been proposed, in- 
cluding translocation from cytosol to endoplasmic rctic- 
ulum [38] and activation by fatty acids and phospholip- 
ids [24,25]. Studies with whole lung tissue on hormonal 
stimulation of PC  synthesis have yielded a considerable 
body of evidence in favor of a regulatory role of the 
cytosolic part of the enzyme in pulmonary PC  metabo- 
lism (see [39] for review). On the other hand, upon 
administration of dexamethasone to pregnant rats, Post 
[14] observed that the increased rate of PC synthesis in 
the type II cells isolated from the lungs of the fetuses 
was accompanied by an increased microsomal CPCT 
activity without a change in the cytosolic activity. Re- 
cently, Rooney et al. [23] observed that glucocorticoids 
increased the activity but not the amount of CPCT in 
explants of fetal rat lungs. Based on this and other 
observations ( ee section 1) they suggested that the stim- 
ulatory effect of glueocorticoids on CPCT activity in 
fetal lung is s~ondary to an acceleration of the synthe- 
sis of fatty acids which, either in free form or after 
incorporation into phospholipids, activate existing 
CPCT molecules. Our earlier observation [16] that fi- 
broblast-conditioned, cortisol-containing medium stim- 
ulates fatty acid synthesis in type II cells is in agreement 
with this hypothesis. In view of the present observation 
that fibroblast-type II cell interaction is involved in the 
pre-translational regulation of FAS, Ace  and ACL it 
is very well possible that the stimulation of CPCT activ- 
ity in fetal type I1 cells by FPF [11] results, at least 
partially, from increased fatty acid synthesis brought 
about by this factor. 
Although the observations on the ore-translational 
regulation of fatty acid synthesis are in agreement with 
the hypothesis that glucocorticoids increase the activity 
of CPCT via induction of fatty acid synthesis, we found 
that exposure of fetal type 1I cells to fibroblast-eondi- 
tioned, cortisol-containing medium does not only lead 
to an increased rate of fatty acid synthesis in these cells, 
but also to increased abundance of CPCT mRNA 
(Table 1). Though the latter effect is less pronounced, 
it does suggest that the increased CPCT activity .seen in 
type II cells upon exposure to this medium [11], and in 
lung tissue upon glucocorticoid treatment [20,40], is not 
only due to stimulation by an increased amount of fatty 
acids or phospholipids synthesized therefrom, but also, 
in part, to pre-translational regulation of CPCT itself. 
It is of note that in the experiments by Rooney et al. [23], 
in which an effect of  glucoeorticoid on CPCT aelivity, 
but not on CPCT amount, in fetal lung explants was 
observed, only the cytosolic fraction was studied. The 
possibility that pre-translational regulation of CPCT is 
involved in the enhancement of the CPCT activity ob- 
served in the microsoma! fraction upon dexamethasone 
exposure of fetal rat lung explants [40] cannot be ex- 
cluded. Pre-translational regulation of CPCT was re- 
cently also observed in a macrophage c ll-line [41]. 
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